OMER Competitors & Alternatives
Compare Omeros Corporation with similar stocks in the same industry
Biotechnology
OMER
Main Stock$18.15
Tradestie Score
64
Market Cap
$281.75M
P/E Ratio
14.2
Revenue Growth
0.1%
Analyst Upside
+51.5%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$27.02
|
$1.32B | - | 45 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.52
|
$1.29B | - | 39 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$27.76
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 65 | Compare |
|
ZYME
Zymeworks Inc.
|
$29.07
|
$1.28B | 59.4 | 42 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.29
|
$1.27B | - | 57 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.72
|
$1.18B | 45.2 | 60 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$51.19
|
$1.17B | - | 33 | Compare |
More OMER Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry